Discover how a BRCA1/2-negative Stage IIIC HGSC ovarian cancer patient overcame multiple brain metastases with surgery, targeted radiotherapy, and olaparib maintenance—remaining disease-free 63 months after diagnosis.
Defying Stage IIIC Ovarian Cancer: One Patient’s 63-Month Triumph Read More »
Discover how one 74-year-old patient with BRCA2-mutated Stage IVB ovarian cancer achieved 57 months of survival and avoided brain metastasis recurrence through gamma knife radiotherapy, targeted chemotherapy, and PARP inhibition.
Triumph Over Advanced HGSC: A 74-Year-Old’s 57-Month Survival Story Read More »
A second chance after a devastating stage 4 lung cancer diagnosis: Discover how Andrea R. regained hope through immunotherapy and the dedicated care of her medical team.
Finding Light in the Darkest Hour: A Busy Mom’s Stage IV Lung Cancer Miracle Read More »
A 53-year-old named Laurent was diagnosed with stage 4 lung cancer in June 2018. After immunotherapy and chemotherapy, he is now nearly in complete remission—proof that hope and advanced treatments can make all the difference.
Finding Hope and Strength: Laurent’s Triumph Over Stage IV Lung Cancer Read More »
Tejas P., MD, Assistant Professor, Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus, and lung cancer survivor Lysa B. discuss how targeted therapy for ROS1-positive lung cancer offers hope and a better quality of life.
Rewriting the Rules: 12 Years of Targeted Therapy for Lysa’s Rare Lung Cancer Read More »
“There is much more hope.” These words from a 9+ year stage IV NSCLC survivor resonate deeply. Her journey, marked by multiple recurrences and triumphs, showcases the remarkable advancements in lung cancer treatment and the power of personalized medicine
Thriving 9½ Years with Recurrences – “Winning” with New Treatments Read More »
Man with stage IV lung cancer gets new lease of life after immunotherapy at Gurgaon hospital. Now nearly 80, he’s back on his feet, playing golf, and thriving years after his diagnosis.
Man with stage IV lung cancer gets new lease of life after immunotherapy Read More »
A Stage 4 lung cancer diagnosis nearly sidelined 33-year-old teacher and athlete, Adrian C. Thanks to precision therapies and supportive care, he reclaimed his active lifestyle—proving that advanced treatments can turn “bonus time” into a hopeful, fulfilling future.
A Remarkable Return to Teaching and Sports After Stage IV Lung Cancer Read More »
A Stage IV non-small cell lung cancer diagnosis at age 42 surprised Anne P., a never-smoker and mother of two. Thanks to comprehensive genomic tumor testing, she now uses targeted therapy for her EGFR- and T790M-positive lung tumors, maintaining an active life and raising awareness about lung cancer research.
“Incurable” Advanced NSCLC to Active Lifestyle Read More »
Genomic testing unlocked a miracle for this survivor, transforming Amy Grove’s difficult Stage IV diagnosis into a stable and hopeful future.
Life-Saving Biomarker Test – MET Amplification “Miracle” Read More »
